Terlipressin Induced Severe Hyponatremia
Terlipressin is a vasopressin analogue used for its vasoconstrictor effect in the treatment of variceal bleeding. Despite its good safety profile compared to vasopressin, some adverse reactions may occur during its use – e.g. hyponatremia. We describe a case of a cirrhotic patient with active varice...
Main Authors: | Martin Šíma, Miroslav Pokorný, František Paďour, Ondřej Slanař |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2016-01-01
|
Series: | Prague Medical Report |
Subjects: | |
Online Access: | https://pmr.lf1.cuni.cz/117/1/0068/ |
Similar Items
-
Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient
by: Yao-Kuang Wang, et al.
Published: (2013-12-01) -
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension
by: Xv Han, et al.
Published: (2020-06-01) -
Terlipressin‐induced foot ischemia
by: Fateen Ata, et al.
Published: (2021-01-01) -
In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2
by: Jamil K, et al.
Published: (2017-12-01) -
Inappropriate Arginine Vasopressin Levels and Hyponatremia Associated with Cyclic Vomiting Syndrome
by: Anders Breinbjerg, et al.
Published: (2015-01-01)